The Stewart group are grateful to the organisers of the recent Frontiers in Cardiovascular Biology (FCVB) meeting in Vienna, Austria, which was held between 20-22nd April. Dr Alan Stewart, Dr Siavash Khazaipoul and Amelie Sobczak were in attendance for the three-day conference and both Siavash and Amelie (pictured below) presented posters on their work.
Related topics
Share this story
Recent Posts
- PhD Opportunity – Multimorbidity Doctoral Training Programme: Thrombo-Inflammation and Clinical Outcomes in Survivors of Childhood Cancer
- PhD Opportunity – Multimorbidity Doctoral Training Programme: Addressing Multimorbidity to Promote Physical Activity & Healthy Ageing in Osteoarthritis Requiring Arthroplasty
- PhD Opportunity – Multimorbidity Doctoral Training Programme: How Commercial Determinants of Health Influence the Development of Multimorbidity
- PhD Opportunity – Multimorbidity Doctoral Training Programme: MLTC Trajectories in People of Working Age and Fitness to Work
- PhD Opportunity – Multimorbidity Doctoral Training Programme: Identifying People with MLTC in Unscheduled Care in the Last Year of Life
Most read
Dean of Medicine to lead national pandemic partnership
Society for Academic Primary Care (SAPC) conference 2026 will be held in St Andrews
PhD Opportunity – Multimorbidity Doctoral Training Programme: The Burden of Multimorbidity Following Tuberculosis (TB) in Uganda
PhD Opportunity – Multimorbidity Doctoral Training Programme: Identifying People with MLTC in Unscheduled Care in the Last Year of Life
PhD Opportunity – Multimorbidity Doctoral Training Programme: MLTC Trajectories in People of Working Age and Fitness to Work
PhD Opportunity – Multimorbidity Doctoral Training Programme: How Commercial Determinants of Health Influence the Development of Multimorbidity
PhD Opportunity – Multimorbidity Doctoral Training Programme: Addressing Multimorbidity to Promote Physical Activity & Healthy Ageing in Osteoarthritis Requiring Arthroplasty
PhD Opportunity – Multimorbidity Doctoral Training Programme: Thrombo-Inflammation and Clinical Outcomes in Survivors of Childhood Cancer